Bosutris 100 Tablet
Marketer
Mylan Pharmaceuticals Pvt Ltd - A Viatris Company
Salt Composition
Bosutinib (100mg)
Overview Bosutris 100 Tablet
Myeloid leukemia medication, Bosutris 100mg tablets, combats cancerous cell proliferation in chronic myeloid leukemia. This treatment inhibits tumor growth and spread, thereby managing disease progression. Dosage and duration should strictly follow your physician's instructions. Consumption with or without food is acceptable; consistent daily intake at the same time improves adherence. Abrupt cessation is discouraged; continue as prescribed. Frequently reported side effects include respiratory infections, nasopharyngitis, thrombocytopenia, leukopenia, anemia, headache, dyspnea, cough, elevated liver enzymes, diarrhea, vomiting, nausea, and abdominal pain. Report any concerning symptoms to your doctor; management strategies may be available. Seek immediate medical attention for severe headaches, unilateral leg swelling, dyspnea, or visual/auditory changes. Prior to commencing Bosutris 100mg, disclose all existing health conditions and medications. This medication is contraindicated during pregnancy and breastfeeding due to potential fetal harm.
Uses of Bosutris 100 Tablet
Chronic myelogenous leukemia, a type of blood malignancy
Major Benefits of Bosutris 100 Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Swallow the Bosutris 100 Tablet whole; avoid chewing, crushing, or breaking it. While you can take it with or without food, consistency is key—take it at the same time each day.
Common Side effects of Bosutris 100 Tablet:
- Abdominal pain
- Nausea
- Vomiting
- Diarrhea
- Headache
- Cough
- Low blood platelets
- Anemia (low number of red blood cells)
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Respiratory tract infection
- Decreased white blood cell count (neutrophils)
- Breathlessness
- Increased liver enzymes
How to use Bosutris 100 Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Bosutris 100 Tablets can be administered with or without food; however, consistent timing is recommended.
How Bosutris 100 Tablet works:
Oncasin 100mg tablets function as a tyrosine kinase inhibitor, employed in cancer treatment. Its mechanism involves neutralizing an aberrant protein responsible for cancerous proliferation and metastasis, thereby inhibiting or retarding tumor growth.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Bosutris 100 Tablet lacks established safety data. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Taking Bosutris 100 Tablet during pregnancy poses a confirmed risk to the fetus. Its use should be avoided except in rare, life-threatening circumstances where a physician deems the potential benefits outweigh the hazards. Always seek medical advice before taking this medication.
Breast feedingCONSULT YOUR DOCTOR
The use of Bosutris 100 Tablet while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingCONSULT YOUR DOCTOR
The effect of Bosutris 100 Tablet on driving ability is undetermined. Refrain from driving if you experience symptoms impairing concentration or reaction time.
KidneyCAUTION
Caution is advised when administering Bosutris 100 Tablets to individuals with impaired renal function. Dosage modification may be necessary. Physician consultation is recommended.
LiverCAUTION
Patients with liver impairment should use Bosutris 100 Tablet cautiously, as dose modification may be necessary. Physician consultation is advised.
What if you forget to take Bosutris 100 Tablet :
Omit any missed Bosutris 100 Tablet dose; resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Bosutris 100 Tablet
| Label | Value |
|---|---|
| Chemical Type | Aminoquinoline derivatives |
| Developing Habits | No. |
| Treatment Category | Cancer Therapeutics |
| Action Class | TKIs (tyrosine kinase inhibitors) |
3,018 People bought this recently